PPARγ recruitment to active ERK during memory consolidation is required for alzheimer's disease-related cognitive enhancement

Jordan B. Jahrling, Caterina M. Hernandez, Larry Denner, Kelly Dineley

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Cognitive impairment is a quintessential feature of Alzheimer's disease (AD) and AD mouse models. The peroxisome proliferator-activated receptor-γ (PPARγ) agonist rosiglitazone improves hippocampus-dependent cognitive deficits in some AD patients and ameliorates deficits in the Tg2576 mouse model for AD amyloidosis. Tg2576 cognitive enhancement occurs through the induction of a gene and protein expression profile reflecting convergence of the PPARγ signaling axis and the extracellular signal-regulated protein kinase (ERK) cascade, a critical mediator of memory consolidation. We therefore tested whether PPARγ and ERK associated in protein complexes that subserve cognitive enhancement through PPARγ agonism. Coimmunoprecipitation of hippocampal extracts revealed that PPARγ and activated, phosphorylated ERK (pERK) associated in Tg2576 in vivo, and that PPARγ agonism facilitated recruitment of PPARγ to pERK during memory consolidation. Furthermore, the amount of PPARγ recruited to pERK correlated with the cognitive reserve in humans with AD and in Tg2576. Our findings implicate a previously unidentified PPARγ-pERK complex that provides a molecular mechanism for the convergence of these pathways during cognitive enhancement, thereby offering new targets for therapeutic development in AD.

Original languageEnglish
Pages (from-to)4054-4063
Number of pages10
JournalJournal of Neuroscience
Volume34
Issue number11
DOIs
StatePublished - 2014

Fingerprint

Peroxisome Proliferator-Activated Receptors
Alzheimer Disease
rosiglitazone
Cognitive Reserve
Memory Consolidation
Extracellular Signal-Regulated MAP Kinases
Amyloidosis
Transcriptome
Protein Kinases
Hippocampus
Proteins

Keywords

  • Alzheimer's
  • Hippocampus
  • In vitro reconstitution
  • Protein complex
  • Transgenic

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

PPARγ recruitment to active ERK during memory consolidation is required for alzheimer's disease-related cognitive enhancement. / Jahrling, Jordan B.; Hernandez, Caterina M.; Denner, Larry; Dineley, Kelly.

In: Journal of Neuroscience, Vol. 34, No. 11, 2014, p. 4054-4063.

Research output: Contribution to journalArticle

@article{0e15c9a013564775a50cd7715d09abc2,
title = "PPARγ recruitment to active ERK during memory consolidation is required for alzheimer's disease-related cognitive enhancement",
abstract = "Cognitive impairment is a quintessential feature of Alzheimer's disease (AD) and AD mouse models. The peroxisome proliferator-activated receptor-γ (PPARγ) agonist rosiglitazone improves hippocampus-dependent cognitive deficits in some AD patients and ameliorates deficits in the Tg2576 mouse model for AD amyloidosis. Tg2576 cognitive enhancement occurs through the induction of a gene and protein expression profile reflecting convergence of the PPARγ signaling axis and the extracellular signal-regulated protein kinase (ERK) cascade, a critical mediator of memory consolidation. We therefore tested whether PPARγ and ERK associated in protein complexes that subserve cognitive enhancement through PPARγ agonism. Coimmunoprecipitation of hippocampal extracts revealed that PPARγ and activated, phosphorylated ERK (pERK) associated in Tg2576 in vivo, and that PPARγ agonism facilitated recruitment of PPARγ to pERK during memory consolidation. Furthermore, the amount of PPARγ recruited to pERK correlated with the cognitive reserve in humans with AD and in Tg2576. Our findings implicate a previously unidentified PPARγ-pERK complex that provides a molecular mechanism for the convergence of these pathways during cognitive enhancement, thereby offering new targets for therapeutic development in AD.",
keywords = "Alzheimer's, Hippocampus, In vitro reconstitution, Protein complex, Transgenic",
author = "Jahrling, {Jordan B.} and Hernandez, {Caterina M.} and Larry Denner and Kelly Dineley",
year = "2014",
doi = "10.1523/JNEUROSCI.4024-13.2014",
language = "English",
volume = "34",
pages = "4054--4063",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "11",

}

TY - JOUR

T1 - PPARγ recruitment to active ERK during memory consolidation is required for alzheimer's disease-related cognitive enhancement

AU - Jahrling, Jordan B.

AU - Hernandez, Caterina M.

AU - Denner, Larry

AU - Dineley, Kelly

PY - 2014

Y1 - 2014

N2 - Cognitive impairment is a quintessential feature of Alzheimer's disease (AD) and AD mouse models. The peroxisome proliferator-activated receptor-γ (PPARγ) agonist rosiglitazone improves hippocampus-dependent cognitive deficits in some AD patients and ameliorates deficits in the Tg2576 mouse model for AD amyloidosis. Tg2576 cognitive enhancement occurs through the induction of a gene and protein expression profile reflecting convergence of the PPARγ signaling axis and the extracellular signal-regulated protein kinase (ERK) cascade, a critical mediator of memory consolidation. We therefore tested whether PPARγ and ERK associated in protein complexes that subserve cognitive enhancement through PPARγ agonism. Coimmunoprecipitation of hippocampal extracts revealed that PPARγ and activated, phosphorylated ERK (pERK) associated in Tg2576 in vivo, and that PPARγ agonism facilitated recruitment of PPARγ to pERK during memory consolidation. Furthermore, the amount of PPARγ recruited to pERK correlated with the cognitive reserve in humans with AD and in Tg2576. Our findings implicate a previously unidentified PPARγ-pERK complex that provides a molecular mechanism for the convergence of these pathways during cognitive enhancement, thereby offering new targets for therapeutic development in AD.

AB - Cognitive impairment is a quintessential feature of Alzheimer's disease (AD) and AD mouse models. The peroxisome proliferator-activated receptor-γ (PPARγ) agonist rosiglitazone improves hippocampus-dependent cognitive deficits in some AD patients and ameliorates deficits in the Tg2576 mouse model for AD amyloidosis. Tg2576 cognitive enhancement occurs through the induction of a gene and protein expression profile reflecting convergence of the PPARγ signaling axis and the extracellular signal-regulated protein kinase (ERK) cascade, a critical mediator of memory consolidation. We therefore tested whether PPARγ and ERK associated in protein complexes that subserve cognitive enhancement through PPARγ agonism. Coimmunoprecipitation of hippocampal extracts revealed that PPARγ and activated, phosphorylated ERK (pERK) associated in Tg2576 in vivo, and that PPARγ agonism facilitated recruitment of PPARγ to pERK during memory consolidation. Furthermore, the amount of PPARγ recruited to pERK correlated with the cognitive reserve in humans with AD and in Tg2576. Our findings implicate a previously unidentified PPARγ-pERK complex that provides a molecular mechanism for the convergence of these pathways during cognitive enhancement, thereby offering new targets for therapeutic development in AD.

KW - Alzheimer's

KW - Hippocampus

KW - In vitro reconstitution

KW - Protein complex

KW - Transgenic

UR - http://www.scopus.com/inward/record.url?scp=84896753835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896753835&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.4024-13.2014

DO - 10.1523/JNEUROSCI.4024-13.2014

M3 - Article

VL - 34

SP - 4054

EP - 4063

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 11

ER -